There are 2789 resources available
869P - Nivolumab (Nivo) and ipilimumab (Ipi) combined with radiotherapy (RT) in patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN): Updated results of a pilot study
Presenter: Jennifer Johnson
Session: ePoster Display
870P - Comparison of PD-L1 and VISTA expression levels in head and neck cancers in primary and recurrent tumor tissue after radiotherapy/chemoradiotherapy
Presenter: Görkem Yazıcı Şener
Session: ePoster Display
871P - Uptake of concurrent chemoradiation in stage 2 nasopharyngeal cancer (NPC): A population-based outcomes study
Presenter: Teng Hwee Tan
Session: ePoster Display
872P - Association between event-free (EFS) and overall survival (OS) in newly diagnosed patients (pts) with locally advanced (LA) head and neck squamous cell carcinoma (HNSCC) ineligible for surgery
Presenter: Christopher Black
Session: ePoster Display
873P - Early efficacy prediction of nasopharyngeal carcinoma based on 3D-ADC acquired during radiotherapy: A phase II prospective study
Presenter: Mei Feng
Session: ePoster Display
874P - Concurrent chemoradiation with cisplatin alone versus cisplatin and capecitabine in treatment of locally advanced head and neck cancer
Presenter: Abhishek Krishna
Session: ePoster Display
Resources:
Abstract
875P - Definitive chemo-IMRT in locally advanced head and neck squamous cell carcinoma (LAHN-SCC): An experience with geriatric patients
Presenter: Imtiaz Ahmed
Session: ePoster Display
876P - Automatic segmentation of organs at risk in head and neck using 3D-UNets
Presenter: Swapneel Datta
Session: ePoster Display
Resources:
Abstract
877P - Comparison of dosimetric benefits in nasopharyngeal carcinoma patients among intensity-modulated radiotherapy, volumetric-modulated arc therapy and tomotherapy
Presenter: Wei Xiong
Session: ePoster Display